Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PHLAX vs. QAAGZX: which is better?

Bottom line

PHLAX vs QAAGZX: the short answer

PHLAX (PGIM Jennison Health Sciences Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 51% by weight.

But QAAGZX is far broader, holding 277 positions to 55 for PHLAX, so beyond the top names it adds exposure PHLAX doesn't have.

QAAGZX is cheaper at 0.86% vs 1.15% — a difference of $29 a year per $10,000 invested.

Over five years, PHLAX returned +5.5% a year vs +4.1% for QAAGZX (reporting dates differ).

PHLAX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

PHLAX vs QAAGZX side by side

PHLAXQAAGZX
TypeMutual fundETF
Fund familyPGIM (Prudential)T. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.15%0.86%
Annual cost per $10k$115$86
10-yr cost on $10k (prospectus)$1,871$1,061
Max front load5.5%None
12b-1 fee0.3%0%
1-yr return+12.7%+18.1%
5-yr return (annualized)+5.5%+4.1%
10-yr return (annualized)+8.9%+9.0%
Best quarter—+23.4%
Worst quarter—−15.8%
Net assets (fund)$1.4B$751.7M
Number of holdings55277
Portfolio turnover81%65%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

9 of PHLAX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingPHLAXQAAGZX
Eli Lilly & Company17.35%14.06%
Merck & Company Inc6.06%4.00%
Unitedhealth Group Inc5.87%5.88%
Thermo Fisher Scientific Inc4.56%2.53%
Vertex Pharmaceuticals Inc3.37%2.26%
Danaher Corp3.28%1.44%
Intuitive Surgical Inc3.07%1.89%
Cvs Health Corp2.52%0.93%
Stryker Corp2.16%1.78%

Source: SEC Form N-PORT

PHLAX top 10

  1. Eli Lilly & Company — 17.35%
  2. Merck & Company Inc — 6.06%
  3. Unitedhealth Group Inc — 5.87%
  4. Thermo Fisher Scientific Inc — 4.56%
  5. Argenx Se — 3.55%
  6. Vertex Pharmaceuticals Inc — 3.37%
  7. Danaher Corp — 3.28%
  8. Intuitive Surgical Inc — 3.07%
  9. Lonza Group Ag — 3.02%
  10. Cvs Health Corp — 2.52%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between PHLAX and QAAGZX?
PHLAX (PGIM Jennison Health Sciences Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 51% by weight. But QAAGZX is far broader, holding 277 positions to 55 for PHLAX, so beyond the top names it adds exposure PHLAX doesn't have.
Which is cheaper, PHLAX or QAAGZX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both PHLAX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.